Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON29585Active, not recruiting
Randomised, double-blind trial in hyperglycemia comparing Liraglutide with Placebo (2 arms). Primary endpoint: Proportion of patients needing perioperative insulin therapy. Started Jun 2017; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON29585.